<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Body dysmorphic disorder: Epidemiology and pathogenesis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Body dysmorphic disorder: Epidemiology and pathogenesis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Body dysmorphic disorder: Epidemiology and pathogenesis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Katharine A Phillips, MD, DLFAPA
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joel Dimsdale, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Solomon, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 18, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3196258942">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Body dysmorphic disorder (BDD) is characterized by excessive preoccupation with nonexistent or slight defects in physical appearance, such that patients believe they look abnormal, unattractive, ugly, or deformed, when in reality they look normal. The preoccupation with perceived flaws leads to repetitive behaviors (eg, checking their appearance in mirrors), which are usually difficult to control and are not pleasurable. In addition, the appearance preoccupations cause clinically significant distress or impaired functioning. BDD is common but underrecognized, and it is often associated with suicidal ideation and behavior.
        </p>
        <p>
         Patients with BDD may present to mental health professionals as well as other clinicians, such as dermatologists, plastic surgeons, otolaryngologists, primary care clinicians, pediatricians, gynecologists, and dentists. Most patients seek nonpsychiatric cosmetic treatment (most commonly dermatologic and surgical) for their perceived physical defects; this treatment appears to be ineffective for most patients and can be risky for clinicians to provide. By contrast, pharmacotherapy (selective serotonin reuptake inhibitors or
         <a class="drug drug_general" data-topicid="9283" href="/z/d/drug information/9283.html" rel="external">
          clomipramine
         </a>
         ) and/or cognitive-behavioral therapy tailored specifically to BDD are often efficacious.
        </p>
        <p>
         This topic reviews the epidemiology and pathogenesis of BDD. The clinical features, assessment, diagnosis, differential diagnosis, treatment, and prognosis of BDD are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14825.html" rel="external">
          "Body dysmorphic disorder: Clinical features"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/96883.html" rel="external">
          "Body dysmorphic disorder: Assessment, diagnosis, and differential diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/117786.html" rel="external">
          "Body dysmorphic disorder: General principles of treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/96504.html" rel="external">
          "Body dysmorphic disorder: Choosing treatment and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3081230006">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The point prevalence of body dysmorphic disorder (BDD) in the general adult population across multiple countries is approximately 2 to 3 percent [
         <a href="#rid1">
          1-6
         </a>
         ]. In clinical settings, the point prevalence is usually higher, ranging from approximately 3 to 40 percent, depending upon the study sample [
         <a href="#rid7">
          7-10
         </a>
         ]. The mean age of onset is approximately 16 to 17 years, with onset before age 18 in two-thirds of cases [
         <a href="#rid11">
          11
         </a>
         ]. Onset is usually gradual rather than abrupt [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H506322828">
         <span class="h2">
          General population
         </span>
         <span class="headingEndMark">
          —
         </span>
         The estimated point prevalence of BDD in the general population, based upon community studies from Australia, China, Germany, Italy, Pakistan, Sweden, Turkey, and the United States, is as follows [
         <a href="#rid1">
          1-6,13,14
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adolescents – 2 to 5 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         College/university students – 3 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adults – 2 to 3 percent
        </p>
        <p>
        </p>
        <p>
         Subsequent studies report even higher prevalence rates [
         <a href="#rid15">
          15-17
         </a>
         ].
        </p>
        <p>
         In nationwide, population-based epidemiologic studies in Western countries, the point prevalence of BDD is higher in younger adults than older adults, and higher in females than males (in a ratio of approximately 1:0.3 to 0.9).
        </p>
        <p class="headingAnchor" id="H1876501470">
         <span class="h2">
          Clinical settings
         </span>
         <span class="headingEndMark">
          —
         </span>
         BDD is common in clinical settings; however, it usually goes undiagnosed [
         <a href="#rid7">
          7
         </a>
         ]. In six studies, none of the patients identified as having BDD by researchers had the diagnosis recorded in their clinical records [
         <a href="#rid8">
          8,9,18
         </a>
         ]. Thus, it is important to screen for BDD in clinical settings. (See
         <a class="medical medical_review" href="/z/d/html/96883.html" rel="external">
          "Body dysmorphic disorder: Assessment, diagnosis, and differential diagnosis", section on 'Screening instruments'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2905320133">
         <span class="h3">
          Psychiatric
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prevalence of BDD in psychiatric settings is as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inpatients
         </strong>
         – A meta-analysis pooled four studies in adult psychiatric inpatients (total n = 788), who were diagnosed with anxiety, bipolar, depressive, psychotic, substance use, and other mental disorders. The point prevalence of comorbid BDD was approximately 7 percent [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Outpatients
         </strong>
         – A meta-analysis of three studies in adult psychiatric outpatients (total n = 765) found that the point prevalence of BDD was approximately 6 percent [
         <a href="#rid2">
          2
         </a>
         ]. BDD was often comorbid with other disorders, such as anxiety, depressive, and substance use disorders. Even higher rates of BDD are found in certain psychiatric subgroups, including patients with anxiety disorders, obsessive-compulsive disorder, atypical major depressive disorder, and eating disorders [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3599199804">
         <span class="h3">
          Cosmetic surgery
         </span>
         <span class="headingEndMark">
          —
         </span>
         A meta-analysis of 11 studies in general cosmetic surgery clinics (total n = 2291 patients) found that the point prevalence of BDD was approximately 13 percent [
         <a href="#rid2">
          2
         </a>
         ]. However, heterogeneity across studies was large. Although females outnumber males in most clinical settings, the prevalence of BDD in general cosmetic surgery settings was higher in males.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rhinoplasty
         </strong>
         – A meta-analysis of seven studies in patients seeking rhinoplasty surgery (total n = 1001) found that the point prevalence of BDD was approximately 20 percent [
         <a href="#rid2">
          2
         </a>
         ]. However, heterogeneity across studies was large. Thus, BDD appears more common in rhinoplasty settings than in general cosmetic surgery settings, which is consistent with findings that the nose is one of the most common body areas of concern in patients with BDD.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Orthognathic surgery
         </strong>
         – A meta-analysis of two studies in patients seeking orthognathic surgery (total n = 259) found that the point prevalence of BDD was approximately 11 percent [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Orthodontic/cosmetic dentistry
         </strong>
         – Based upon multiple reviews, the point prevalence of BDD in orthodontic and cosmetic dentistry patients is approximately 5 to 10 percent [
         <a href="#rid2">
          2,19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H138845431">
         <span class="h3">
          Dermatology
         </span>
         <span class="headingEndMark">
          —
         </span>
         A meta-analysis of five studies in general dermatology outpatient clinics (total n = 914 patients) estimated that the point prevalence of BDD was 11 percent [
         <a href="#rid2">
          2
         </a>
         ]. However, heterogeneity across studies was large, and one review found that the prevalence of BDD ranged from 7 to 42 percent of the dermatology patients [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H173546496">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the pathogenesis of body dysmorphic disorder (BDD) remains largely unknown, the etiology is likely multifactorial, involving biologic (including evolutionary), psychologic, and social factors [
         <a href="#rid20">
          20-22
         </a>
         ]. Studies of the pathogenesis have used cross-sectional designs, making it unclear whether abnormalities (eg, neuroimaging findings) represent etiologic causes, sequelae, neither, or both.
        </p>
        <p class="headingAnchor" id="H2824998298">
         <span class="h2">
          Heritability/genetics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Based upon multiple twin studies, the heritability of BDD is moderate [
         <a href="#rid23">
          23
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A study of monozygotic and dizygotic female twin pairs (total n &gt;5400) found that the relative contribution of genetic factors (heritability) to BDD was 43 percent, and the remaining contribution was attributable to environmental factors [
         <a href="#rid23">
          23
         </a>
         ]. In addition, the risk of developing BDD involved genetic factors that were shared with obsessive-compulsive disorder, as well as other genetic factors that were unique to BDD.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Another study of monozygotic and dizygotic female twin pairs (total n &gt;3500) examined “dysmorphic concern” (excessive preoccupations with a perceived or slight flaw in physical appearance), which differs from but substantially overlaps with the diagnosis of BDD. The results indicated that dysmorphic concern was a heritable trait, such that 44 percent of the variance in dysmorphic concern was due to genetic factors and 56 percent to nonshared (unique) environmental factors [
         <a href="#rid24">
          24
         </a>
         ]. Also, the association between dysmorphic concern and obsessive-compulsive symptoms appeared to be primarily due to shared genetic factors [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a registry study of twin individuals (n &gt;15,000), the heritability of clinically significant BDD symptoms in adolescents and young adults was as follows [
         <a href="#rid26">
          26
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Age 15 years – 49 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Age 18 years – 39 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Age 20 to 28 years – 37 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The remaining variance was due to nonshared environmental factors.
        </p>
        <p>
        </p>
        <p>
         One preliminary candidate gene study detected an association between BDD and the GABA-A-gamma-2 (5q31.1-q33.2) receptor gene [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1610926962">
         <span class="h2">
          Visual processing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Visuospatial and psychophysical studies of BDD, using tasks such as the Rey-Osterrieth Complex Figure Test, the inverted faces task, and the embedded figures task, have observed enhanced detail-oriented (“local”) visual processing and impaired global (holistic) visual processing [
         <a href="#rid21">
          21,28
         </a>
         ].
        </p>
        <p>
         Functional magnetic resonance imaging (MRI) studies also suggest that BDD is associated with abnormal visual processing, manifesting as overattention to detail accompanied by deficiencies in global/holistic perception [
         <a href="#rid29">
          29-31
         </a>
         ]. These abnormalities may make it difficult to see “the big picture” and to contextualize details, so that miniscule details appear abnormally prominent and out of proportion and thereby flawed and unattractive [
         <a href="#rid32">
          32
         </a>
         ]. As an example, multiple studies used functional MRI to compare BDD patients with healthy controls while viewing faces and objects, and found that patients had hyperactivation (abnormally increased visual processing) in left ventral visual stream (temporal lobe), and hypoactivation (abnormally reduced neural activity) in dorsal visual stream (visual cortex); this suggested greater processing of detail and underutilization of brain systems dedicated to global/holistic (“big picture”) visual processing [
         <a href="#rid29">
          29-31
         </a>
         ]. In addition, BDD symptom severity was correlated with increased frontostriatal activity and activity in extrastriate visual cortex.
        </p>
        <p>
         Other functional MRI studies compared activation and connectivity in BDD and anorexia nervosa, which both involve distorted perception of appearance [
         <a href="#rid12">
          12
         </a>
         ]. One study examined visual information processing of images of faces and houses in patients with BDD or anorexia nervosa and found similar abnormal hypoactivity in visual processing regions for holistic and configural information. However, the BDD group displayed hyperactivity in the fusiform cortex, which correlated with lower attractiveness ratings of others’ faces, and suggested that enhanced detail visual processing in BDD may lead to a greater likelihood of detecting flaws [
         <a href="#rid21">
          21,33
         </a>
         ]. A subsequent study in BDD and anorexia nervosa found partially overlapping as well as different patterns of connectivity when viewing bodies (rather than faces); in both groups of patients, abnormal activity and/or connectivity were directly related to symptom severity and appearance ratings of others’ bodies [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4091948891">
         <span class="h2">
          Anatomic abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         MRI has been used to compare brain structure in BDD patients with that in healthy controls, but the results have varied [
         <a href="#rid21">
          21,35
         </a>
         ]. As an example, two structural MRI studies indicated that total white matter volume was larger in patients with BDD compared with control subjects [
         <a href="#rid36">
          36,37
         </a>
         ], but other studies failed to replicate this finding [
         <a href="#rid38">
          38
         </a>
         ]. In a relatively large morphometric study (BDD, n = 65; healthy controls, n = 68), the BDD group had larger gray matter volume in early extrastriate visual cortex in the occipital lobe [
         <a href="#rid32">
          32
         </a>
         ], which overlaps with regions in which reduced functional activation has been detected when viewing faces and objects [
         <a href="#rid29">
          29,31
         </a>
         ]. (See
         <a class="local">
          'Visual processing'
         </a>
         above.)
        </p>
        <p>
         Increased gray matter volume might reflect insufficient synaptic pruning during neurodevelopment, which could interfere with normal development of holistic/global visual processing strategies and thus manifest as a reduced ability to integrate visual details into a more global context [
         <a href="#rid32">
          32
         </a>
         ]. Alternatively, obsessive preoccupation with appearance and excessive repetitive behaviors such as checking one’s appearance in mirrors might modify early extrastriate architecture and result in larger brain volumes.
        </p>
        <p>
         Studies of white matter integrity in patients and controls have yielded inconsistent results [
         <a href="#rid39">
          39,40
         </a>
         ]. One study of neural networks found that white matter network organization was abnormal in BDD [
         <a href="#rid41">
          41
         </a>
         ], whereas another study did not [
         <a href="#rid40">
          40
         </a>
         ]. However, the latter study found correlations between fiber disorganization and poorer BDD-related insight in white matter tracts that facilitate communication between visual and emotion/memory systems as well as interhemispheric communication [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3045009227">
         <span class="h2">
          Neurocognitive dysfunction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple studies suggest that executive function, which involves cognitive processes such as planning, making decisions, and response inhibition, is impaired in BDD [
         <a href="#rid42">
          42-44
         </a>
         ]. As an example, a study that compared patients (n = 14) with controls who had no psychiatric history (n = 14) found that the ability to plan and to manipulate and organize information was inferior in BDD patients [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
         Deficits in executive function may represent frontal lobe dysfunction and help explain why patients with BDD focus on specific details of their body rather than the entirety of their appearance [
         <a href="#rid45">
          45
         </a>
         ]. Findings from neuroimaging studies are consistent with this hypothesis.
        </p>
        <p class="headingAnchor" id="H2055353469">
         <span class="h2">
          Emotional processing deficits
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with BDD may also have deficits in recognizing emotions conveyed by the facial expressions of other people [
         <a href="#rid44">
          44
         </a>
         ]. One study of patients with BDD (n = 18) and healthy controls (n = 18) found that patients were more likely to misinterpret neutral facial expressions in photographs as contemptuous and angry [
         <a href="#rid46">
          46
         </a>
         ]. A second study suggested that patients have a bias toward interpreting neutral scenarios as threatening [
         <a href="#rid47">
          47
         </a>
         ]. The results of these studies are consistent with the belief among patients that they are ridiculed and mocked because they look “ugly.”
        </p>
        <p class="headingAnchor" id="H3968607088">
         <span class="h2">
          Childhood maltreatment and trauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies indicate that compared with published norms, patients with BDD report lower than average levels of perceived parental care during childhood, greater teasing by peers, and more maltreatment during childhood (neglect and abuse) [
         <a href="#rid48">
          48,49
         </a>
         ]. As an example, one study found that a history of emotional, physical, and/or sexual abuse was reported by more patients with BDD (n = 50) than patients with obsessive-compulsive disorder (n = 50; 38 versus 14 percent) [
         <a href="#rid50">
          50
         </a>
         ]. Several other studies found that self-reports of childhood maltreatment and early life traumatic events were greater in patients with BDD than healthy controls [
         <a href="#rid51">
          51,52
         </a>
         ]. However, the accuracy of reports of childhood maltreatment in the studies was not confirmed.
        </p>
        <p class="headingAnchor" id="H3559806185">
         <span class="h2">
          Sociocultural factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sociocultural factors such as body ideals and beauty standards appear to increase the risk of developing BDD [
         <a href="#rid22">
          22
         </a>
         ]. In addition, greater use of social media may be associated with poorer body image more generally [
         <a href="#rid53">
          53
         </a>
         ], whereas greater use of image-based social media (eg, Instagram and Snapchat), and greater appearance focus when using social media (eg, filtering self-photos before posting them), may be associated specifically with BDD [
         <a href="#rid15">
          15,16,54
         </a>
         ]. However, the studies of social media and BDD are cross-sectional, and it is thus not known whether certain types of social media increase the likelihood of developing BDD.
        </p>
        <p class="headingAnchor" id="H705456628">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many patients can benefit from reading about their illness at websites such as those maintained by the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fiocdf.org%2F&amp;token=admdKeWmBTLhH584O3g%2BlGzgMPjD4%2FhPhFsi2jrCsM4%3D&amp;TOPIC_ID=118989" target="_blank">
          International OCD Foundation
         </a>
         and the author of this topic at
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.katharinephillipsmd.com%2F&amp;token=VEKFj6DJFyBml8C%2Bpg6UMEmfZEWUp%2BVPwnAxz7eG6e3A8JGAwgug0jhztf%2BXLiZ%2B&amp;TOPIC_ID=118989" target="_blank">
          her website
         </a>
         .
        </p>
        <p class="headingAnchor" id="H1824544012">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – Body dysmorphic disorder (BDD) is diagnosed according to DSM-5-TR criteria  (
         <a class="graphic graphic_table graphicRef96646" href="/z/d/graphic/96646.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/96883.html" rel="external">
          "Body dysmorphic disorder: Assessment, diagnosis, and differential diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Point prevalence
         </strong>
         – The estimated point prevalence of BDD in different populations is as follows:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adult general population – 2 to 3 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Psychiatric patients with other mental disorders (eg, depression) – 6 to 7 percent. The rate is even higher in certain subgroups, such as patients with anxiety disorders, obsessive-compulsive disorder, atypical major depressive disorder, and eating disorders.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cosmetic surgery (including rhinoplasty) patients – 11 to 20 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dermatology patients – 11 to 13 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathogenesis
         </strong>
         –The pathogenesis of BDD is not known. Neuroimaging and other studies suggest that BDD is associated with abnormal visual processing, with a bias for encoding and analyzing details of faces, as well as nonfacial objects, rather than using holistic visual processing strategies (ie, seeing “the big picture”). Other studies suggest that genetic factors; perceived teasing, neglect, and abuse; and sociocultural factors may also play a role. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Hartmann AS, Buhlmann U. Prevalence and underrecognition of body dysmorphic disorder. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice, Phillips KA (Ed), Oxford University Press, New York 2017. p.49.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veale D, Gledhill LJ, Christodoulou P, Hodsoll J. Body dysmorphic disorder in different settings: A systematic review and estimated weighted prevalence. Body Image 2016; 18:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veale D, Bewley A. Body dysmorphic disorder. BMJ 2015; 350:h2278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schieber K, Kollei I, de Zwaan M, Martin A. Classification of body dysmorphic disorder - what is the advantage of the new DSM-5 criteria? J Psychosom Res 2015; 78:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rief W, Buhlmann U, Wilhelm S, et al. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med 2006; 36:877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buhlmann U, Glaesmer H, Mewes R, et al. Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res 2010; 178:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conroy M, Menard W, Fleming-Ives K, et al. Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting. Gen Hosp Psychiatry 2008; 30:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grant JE, Kim SW, Crow SJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry 2001; 62:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zimmerman M, Mattia JI. Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Compr Psychiatry 1998; 39:265.
          </a>
         </li>
         <li class="breakAll">
          Kelly MM, Phillips KA. Phenomenology and epidemiology of body dysmorphic disorder. In: Oxford Handbook of Obsessive Compulsive and Related Disorders, Tolin D (Ed), Oxford University Press, 2023.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bjornsson AS, Didie ER, Grant JE, et al. Age at onset and clinical correlates in body dysmorphic disorder. Compr Psychiatry 2013; 54:893.
          </a>
         </li>
         <li class="breakAll">
          American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, 2013.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Möllmann A, Dietel FA, Hunger A, Buhlmann U. Prevalence of body dysmorphic disorder and associated features in German adolescents: A self-report survey. Psychiatry Res 2017; 254:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider SC, Mond J, Turner CM, Hudson JL. Sex Differences in the Presentation of Body Dysmorphic Disorder in a Community Sample of Adolescents. J Clin Child Adolesc Psychol 2019; 48:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berjaoui A, Chahine B. Body dysmorphic disorder among Lebanese females: A cross-sectional study. J Cosmet Dermatol 2023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alsaidan MS, Altayar NS, Alshmmari SH, et al. The prevalence and determinants of body dysmorphic disorder among young social media users: A cross-sectional study. Dermatol Reports 2020; 12:8774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alghamdi WA, Subki AH, Khatib HA, et al. Body Dysmorphic Disorder Symptoms: Prevalence and Risk Factors in an Arab Middle Eastern Population. Int J Gen Med 2022; 15:2905.
          </a>
         </li>
         <li class="breakAll">
          Kelly MM, Phillips KA. Phenomenology and epidemiology of body dysmorphic disorder: 48. In: The Oxford Handbook of Obsessive Compulsive and Spectrum Disorders, Steketee G (Ed), Oxford University Press, New York 2011.
         </li>
         <li class="breakAll">
          Crerand CE, Sarwer DB, Ryan M. Cosmetic medical and surgical treatments and body dysmorphic disorder. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice, Phillips KA (Ed), Oxford University Press, New York 2017. p.431.
         </li>
         <li class="breakAll">
          Stein DJ. Evolutionary Psychiatry and Body Dysmorphic Disorder. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice, Phillips KA (Ed), Oxford University Press, New York 2017.
         </li>
         <li class="breakAll">
          McCurdy-McKinnon D, Feusner JD. Neurobiology of Body Dysmorphic Disorder: Heritability/Genetics, Brain Circuitry, and Visual Processing. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice, Phillips KA (Ed), Oxford University Press, New York 2017.
         </li>
         <li class="breakAll">
          Neziroglu F, Barile N. Environmental Factors in Body Dysmorphic Disorder. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice, Phillips KA (Ed), Oxford University Press, New York 2017. p.277.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monzani B, Rijsdijk F, Harris J, Mataix-Cols D. The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders. JAMA Psychiatry 2014; 71:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monzani B, Rijsdijk F, Anson M, et al. A twin study of body dysmorphic concerns. Psychol Med 2012; 42:1949.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monzani B, Rijsdijk F, Iervolino AC, et al. Evidence for a genetic overlap between body dysmorphic concerns and obsessive-compulsive symptoms in an adult female community twin sample. Am J Med Genet B Neuropsychiatr Genet 2012; 159B:376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enander J, Ivanov VZ, Mataix-Cols D, et al. Prevalence and heritability of body dysmorphic symptoms in adolescents and young adults: a population-based nationwide twin study. Psychol Med 2018; 48:2740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Phillips KA, Zai G, King NA, et al. A preliminary candidate gene study in body dysmorphic disorder. J Obsessive Compuls Relat Disord 2015; 6:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beilharz F, Castle DJ, Grace S, Rossell SL. A systematic review of visual processing and associated treatments in body dysmorphic disorder. Acta Psychiatr Scand 2017; 136:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feusner JD, Townsend J, Bystritsky A, Bookheimer S. Visual information processing of faces in body dysmorphic disorder. Arch Gen Psychiatry 2007; 64:1417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feusner JD, Hembacher E, Moller H, Moody TD. Abnormalities of object visual processing in body dysmorphic disorder. Psychol Med 2011; 41:2385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feusner JD, Moody T, Hembacher E, et al. Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. Arch Gen Psychiatry 2010; 67:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feusner JD, Kurth F, Luders E, et al. Cytoarchitectonically Defined Volumes of Early Extrastriate Visual Cortex in Unmedicated Adults With Body Dysmorphic Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2023; 8:909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li W, Lai TM, Bohon C, et al. Anorexia nervosa and body dysmorphic disorder are associated with abnormalities in processing visual information. Psychol Med 2015; 45:2111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moody TD, Morfini F, Cheng G, et al. Brain activation and connectivity in anorexia nervosa and body dysmorphic disorder when viewing bodies: relationships to clinical symptoms and perception of appearance. Brain Imaging Behav 2021; 15:1235.
          </a>
         </li>
         <li class="breakAll">
          Phillips KA. Body dysmorphic disorder. In: Handbook on Obsessive-Compulsive and Related Disorders, Phillips KA, Stein DJ (Eds), American Psychiatric Publishing, Arlington 2015.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rauch SL, Phillips KA, Segal E, et al. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res 2003; 122:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atmaca M, Bingol I, Aydin A, et al. Brain morphology of patients with body dysmorphic disorder. J Affect Disord 2010; 123:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feusner JD, Townsend J, Bystritsky A, et al. Regional brain volumes and symptom severity in body dysmorphic disorder. Psychiatry Res 2009; 172:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchanan BG, Rossell SL, Maller JJ, et al. Brain connectivity in body dysmorphic disorder compared with controls: a diffusion tensor imaging study. Psychol Med 2013; 43:2513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feusner JD, Arienzo D, Li W, et al. White matter microstructure in body dysmorphic disorder and its clinical correlates. Psychiatry Res 2013; 211:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arienzo D, Leow A, Brown JA, et al. Abnormal brain network organization in body dysmorphic disorder. Neuropsychopharmacology 2013; 38:1130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanes KR. Neuropsychological performance in body dysmorphic disorder. J Int Neuropsychol Soc 1998; 4:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deckersbach T, Savage CR, Phillips KA, et al. Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc 2000; 6:673.
          </a>
         </li>
         <li class="breakAll">
          Buhlmann U, Hartmann AS. Cognitive and emotional processing in body dysmorphic disorder. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice, Phillips KA (Ed), Oxford University Press, New York 2017. p.285.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dunai J, Labuschagne I, Castle DJ, et al. Executive function in body dysmorphic disorder. Psychol Med 2010; 40:1541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buhlmann U, Etcoff NL, Wilhelm S. Emotion recognition bias for contempt and anger in body dysmorphic disorder. J Psychiatr Res 2006; 40:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buhlmann U, Wilhelm S, McNally RJ, et al. Interpretive biases for ambiguous information in body dysmorphic disorder. CNS Spectr 2002; 7:435.
          </a>
         </li>
         <li class="breakAll">
          Phillips KA. Understanding Body Dysmorphic Disorder: An Essential Guide, Oxford University Press, New York 2009.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Didie ER, Tortolani CC, Pope CG, et al. Childhood abuse and neglect in body dysmorphic disorder. Child Abuse Negl 2006; 30:1105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neziroglu F, Khemlani-Patel S, Yaryura-Tobias JA. Rates of abuse in body dysmorphic disorder and obsessive-compulsive disorder. Body Image 2006; 3:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buhlmann U, Marques LM, Wilhelm S. Traumatic experiences in individuals with body dysmorphic disorder. J Nerv Ment Dis 2012; 200:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malcolm A, Pikoos TD, Grace SA, et al. Childhood maltreatment and trauma is common and severe in body dysmorphic disorder. Compr Psychiatry 2021; 109:152256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelly Y, Zilanawala A, Booker C, Sacker A. Social Media Use and Adolescent Mental Health: Findings From the UK Millennium Cohort Study. EClinicalMedicine 2018; 6:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta M, Jassi A, Krebs G. The association between social media use and body dysmorphic symptoms in young people. Front Psychol 2023; 14:1231801.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 118989 Version 6.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Hartmann AS, Buhlmann U. Prevalence and underrecognition of body dysmorphic disorder. In: Body Dysmorphic Disorder: Advances in Research and Clinical Practice, Phillips KA (Ed), Oxford University Press, New York 2017. p.49.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27498379" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Body dysmorphic disorder in different settings: A systematic review and estimated weighted prevalence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26088615" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25595027" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Classification of body dysmorphic disorder - what is the advantage of the new DSM-5 criteria?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16515733" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The prevalence of body dysmorphic disorder: a population-based survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20452057" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Updates on the prevalence of body dysmorphic disorder: a population-based survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18164943" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11488361" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9777278" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9777278" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23643073" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Age at onset and clinical correlates in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23643073" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Age at onset and clinical correlates in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28482195" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Prevalence of body dysmorphic disorder and associated features in German adolescents: A self-report survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28541768" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Sex Differences in the Presentation of Body Dysmorphic Disorder in a Community Sample of Adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37743744" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Body dysmorphic disorder among Lebanese females: A cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33408841" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The prevalence and determinants of body dysmorphic disorder among young social media users: A cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35300125" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Body Dysmorphic Disorder Symptoms: Prevalence and Risk Factors in an Arab Middle Eastern Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35300125" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Body Dysmorphic Disorder Symptoms: Prevalence and Risk Factors in an Arab Middle Eastern Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35300125" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Body Dysmorphic Disorder Symptoms: Prevalence and Risk Factors in an Arab Middle Eastern Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35300125" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Body Dysmorphic Disorder Symptoms: Prevalence and Risk Factors in an Arab Middle Eastern Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35300125" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Body Dysmorphic Disorder Symptoms: Prevalence and Risk Factors in an Arab Middle Eastern Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35300125" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Body Dysmorphic Disorder Symptoms: Prevalence and Risk Factors in an Arab Middle Eastern Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24369376" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22126745" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : A twin study of body dysmorphic concerns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22434544" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Evidence for a genetic overlap between body dysmorphic concerns and obsessive-compulsive symptoms in an adult female community twin sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29486813" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Prevalence and heritability of body dysmorphic symptoms in adolescents and young adults: a population-based nationwide twin study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : A preliminary candidate gene study in body dysmorphic disorder
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28190269" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : A systematic review of visual processing and associated treatments in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18056550" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Visual information processing of faces in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21557897" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Abnormalities of object visual processing in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20124119" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34688924" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Cytoarchitectonically Defined Volumes of Early Extrastriate Visual Cortex in Unmedicated Adults With Body Dysmorphic Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25652023" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Anorexia nervosa and body dysmorphic disorder are associated with abnormalities in processing visual information.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32875486" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Brain activation and connectivity in anorexia nervosa and body dysmorphic disorder when viewing bodies: relationships to clinical symptoms and perception of appearance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32875486" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Brain activation and connectivity in anorexia nervosa and body dysmorphic disorder when viewing bodies: relationships to clinical symptoms and perception of appearance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12589879" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19846221" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Brain morphology of patients with body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19328661" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Regional brain volumes and symptom severity in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23473554" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Brain connectivity in body dysmorphic disorder compared with controls: a diffusion tensor imaging study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23375265" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : White matter microstructure in body dysmorphic disorder and its clinical correlates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23322186" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Abnormal brain network organization in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9529826" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Neuropsychological performance in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11011514" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Characteristics of memory dysfunction in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11011514" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Characteristics of memory dysfunction in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19951448" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Executive function in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15904932" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Emotion recognition bias for contempt and anger in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15107765" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Interpretive biases for ambiguous information in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15107765" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Interpretive biases for ambiguous information in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17005251" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Childhood abuse and neglect in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18089222" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Rates of abuse in body dysmorphic disorder and obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22210370" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Traumatic experiences in individuals with body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34147729" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Childhood maltreatment and trauma is common and severe in body dysmorphic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31193561" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Social Media Use and Adolescent Mental Health: Findings From the UK Millennium Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37663365" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : The association between social media use and body dysmorphic symptoms in young people.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
